PURPOSE: The purpose of this study was to investigate the feasibility of @entity1600 ( @entity1600 ) identification in @entity1 with @entity1204 . METHODS: Twenty @entity1 with @entity1204 undergoing hysterectomy and lymphadenectomy were included in the study. At laparotomy, @entity6693 dye was injected into the subserosal myometrium of corpus uteri at multiple sites. Dye uptake into lymphatic channels was observed and blue nodes were identified as SLNs. The SLNs were biopsied before lymphadenectomy performed. The samples of SLNs and non-SLNs were recorded separately and correlated with the final pathological results. RESULTS: Dye uptake into lymphatic channels was seen in all 20 cases. Among them, @entity1600 was identified in 15 (75%) cases. A total of 71 SLNs with a mean number of 4.7 @entity1600 (range, 1-10) were identified from all pelvic sites. The most frequent locations of SLNs included obturator in 29 (41%), interiliac in 16 (26%). No dye-containing paraaortic nodes were found. Two @entity1 (10%) had nodal metastases, and they all had at least one @entity1600 found to be positive. No adverse reactions or injures were attributed to the study. CONCLUSIONS: This study shows the feasibility and safety of @entity1600 identification with blue dye in @entity1 with @entity1204 undergoing staging surgery. The approach might provide an alternative to limit the extent of nodal sampling.

A pilot study of sentinel lymph nodes identification in XXXX with @entity1204 .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1600 :: ('MESH:D014388', 'Disease') :: ['sentinel lymph node', 'SLN'] @entity6693 :: ('MESH:D008751', 'Chemical') :: ['methylene blue'] @entity1204 :: ('MESH:D016889', 'Disease') :: ['endometrial cancer']
@entity1 :: (9606,Species) :: ['patients']
